Abstract

BackgroundIron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia.MethodsWe studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding capacity (TIBC<50 µmol/L) in 1011 outpatients with non-dialysis CKD participating in the Nephrotest study. All had glomerular filtration rates measured (mGFR) by 51Cr-EDTA renal clearance; 199 also had hepcidin measures.ResultsThe TSAT-TIBC-ferritin index explained Hb variation better than indexes combining TSAT-TIBC or ferritin-TSAT. It showed hypotransferrinaemia and non-inflammatory functional iron deficiency (ID) to be more common than either absolute or inflammatory ID: 20%, 19%, 6%, and 2%, respectively. Hb was lower in all abnormal, compared with normal, iron profiles, and decreased more when mGFR was below 30 mL/min/1.73 m2 (interaction p<0.0001). In patients with mGFR<30 mL/min/1.73 m2, the Hb decreases associated with hypotransferrinaemia, non-inflammatory functional ID, and absolute ID were 0.83±0.16 g/dL, 0.51±0.18 and 0.89±0.29, respectively. Compared with normal iron profiles, hepcidin was severely depressed in absolute ID but higher in hypotransferrinaemia.ConclusionsThe combined TSAT-TIBC-ferritin index identifies hypotransferrinaemia and non-inflammatory functional ID as the major mechanisms of iron disorders in CKD anaemia. Both disorders were associated with a greater decrease in Hb when mGFR was <30 mL/min/1.73 m2. Taking these iron profiles into account may be useful in stratifying patients in clinical trials of CKD anaemia and might improve the management of iron therapy.

Highlights

  • Anaemia is an early complication of chronic kidney disease (CKD) [1], associated with symptoms, potential need for blood transfusion and increased morbidity and mortality [2]

  • Sub-Saharan African origin, diabetic nephropathy, lower measured glomerular filtration rate (mGFR), higher proteinuria and higher CRP levels were associated with lower Hb levels and higher prevalence of anemia

  • Hb levels did not differ between patients treated with either single or double RAS blockade or folate and those not so treated, but mean Hb was slightly lower in patients receiving oral iron therapy or diuretics

Read more

Summary

Introduction

Anaemia is an early complication of chronic kidney disease (CKD) [1], associated with symptoms, potential need for blood transfusion and increased morbidity and mortality [2]. Iron metabolism disorders are common and complex in CKD, but few studies have investigated their relations with anaemia in early-stage CKD [4,5,6]. Two of these studies examined the relations between Hb and both transferrin saturation (TSAT) and ferritin. Two other studies have showed that iron disorders modify ESA response [6,7]. Iron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call